FAKTOR OPTIONSSCHEIN - ROCHE GS Share Price

Certificat

DE000PD5R0P0

Delayed Deutsche Boerse AG 03:50:54 20/06/2024 pm IST
55.03 EUR -0.52% Intraday chart for FAKTOR OPTIONSSCHEIN - ROCHE GS
Current month-32.84%
1 month-21.79%
Date Price Change
20/24/20 55.03 -0.52%
19/24/19 55.32 -6.21%
18/24/18 58.98 -1.60%
17/24/17 59.94 +2.04%
14/24/14 58.74 -2.55%

Delayed Quote Deutsche Boerse AG

Last update June 20, 2024 at 03:50 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PD5R0P
ISINDE000PD5R0P0
Date issued 10/12/2021
Strike 249.8 CHF
Maturity Unlimited
Parity 1 : 1
Emission price 50
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 141.2
Lowest since issue 23.29
Spread 0.55
Spread %0.98%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
249.8 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.31%
Consensus